Bioavailability is one of those “simple” pharmacology concepts that shows up everywhere—then suddenly you’re asked to compare oral morphine vs IV morphine dosing or explain why nitroglycerin isn’t swallowed. If you can instantly recall what bioavailability (F) means and what lowers it, you’ll save time (and points) on both Step 1 and Step 2.
Bioavailability (F): the one-liner
Bioavailability (F) = the fraction of an administered dose that reaches the systemic circulation unchanged.
- IV dosing: (100%)
- Non-IV dosing: (variable)
The mnemonic: “F = First pass Fights your drug”
Think of the letter F as a bouncer stopping your medication before it reaches the bloodstream:
- F = Fraction that makes it through
- First-pass metabolism “fights” (reduces) your drug before it hits systemic circulation
Quick visual device (sticky-note style)
Oral dose → Gut wall → Portal vein → Liver (FIRST PASS) → Systemic circulation
If your drug gets heavily metabolized in the gut wall or liver on the first trip through, F drops.
What determines bioavailability? (High-yield checklist)
The big two Step favorites
- First-pass metabolism (liver + gut wall) ↓ F
- Poor absorption ↓ F (e.g., unstable in GI tract, poor permeability, interactions)
Other classic testable contributors
- Degradation in the GI tract (acid, enzymes) ↓ F
- Drug-drug/food interactions
- Chelation (e.g., tetracyclines + calcium/iron) ↓ absorption → ↓ F
- CYP/P-gp inhibitors may ↑ F for some drugs (by reducing metabolism/efflux)
- Formulation effects
- Extended-release vs immediate-release can alter rate and sometimes extent of absorption
- Route matters
- Sublingual/Transdermal often bypass first-pass → higher F than oral
Rapid comparisons (the “don’t-mix-these-up” table)
| Route | First-pass effect? | Typical F | High-yield example |
|---|---|---|---|
| IV | No | 1.0 | IV heparin (not absorbed orally anyway) |
| Oral | Yes | Variable, often <1 | Oral propranolol (significant first pass) |
| Sublingual | Bypasses liver first pass | Higher than oral | Nitroglycerin sublingual |
| Rectal | Partial bypass (lower rectum) | Intermediate/variable | Some rectal meds have less first pass |
| IM/SC | No first pass | Variable | Depends on blood flow, formulation |
The equation you’ll actually use on exams
Absolute bioavailability
Compare non-IV to IV exposure using AUC:
Memory hook:
AUC is “Area Under the Curve,” aka total drug exposure → more AUC = more drug reached systemic circulation.
Mini USMLE-style pearls (quick-hit)
- If first-pass metabolism is high, you often need a higher oral dose to achieve the same effect as IV.
- Nitroglycerin is given sublingually because swallowed nitro gets crushed by first-pass metabolism → very low oral F.
- IV is always 100% bioavailable, but that does not guarantee longer duration—duration depends more on distribution and clearance.
Ultra-shareable recap (tweet-length)
Bioavailability (F) = fraction of dose reaching blood unchanged.
Mnemonic: “F = First pass Fights your drug.”
IV: ; Oral: due to first-pass + absorption limits.
Frequently Asked Questions
What does bioavailability mean in pharmacology?
Bioavailability is the fraction of an administered dose that reaches the systemic circulation unchanged. For IV dosing, bioavailability is 1 because the drug enters the bloodstream directly. For non-IV routes, bioavailability is less than 1 and varies depending on how much drug is absorbed and how much is lost before reaching systemic circulation.
Why does first-pass metabolism lower bioavailability?
First-pass metabolism lowers bioavailability because the drug is metabolized in the gut wall or liver before it reaches the systemic circulation. With an oral dose, the drug passes through the gut wall, portal vein, and liver first, so heavy metabolism on this first trip reduces the fraction of unchanged drug that ultimately gets into the bloodstream.
Why is nitroglycerin given sublingually instead of swallowed?
Nitroglycerin is given sublingually because swallowed nitroglycerin undergoes major first-pass metabolism, which gives it very low oral bioavailability. The sublingual route bypasses liver first-pass metabolism, so a greater fraction of the unchanged drug reaches the systemic circulation compared with taking it by mouth.
What factors decrease oral bioavailability?
Oral bioavailability decreases mainly because of first-pass metabolism and poor absorption. It can also fall due to degradation in the GI tract from acid or enzymes, drug-drug or food interactions such as chelation with calcium or iron, and formulation effects that alter absorption. These processes reduce how much unchanged drug reaches the bloodstream.
How do you calculate absolute bioavailability on an exam?
Absolute bioavailability is calculated by comparing non-IV exposure with IV exposure using AUC, which represents total drug exposure. The formula is F = (AUC non-IV / AUC IV) × (Dose IV / Dose non-IV). This tells you what fraction of a non-IV dose reaches systemic circulation relative to an IV dose, which is treated as fully bioavailable.